Announcements Trials
Browse Landscape

Phase

Phase 3 4Phase 2 4Phase NA 3Phase EARLY_PHASE1 1Phase 4 1Phase 1 1

Status

Completed 8Terminated 4Unknown 3Recruiting 2Withdrawn 1Suspended 1Active not recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pain 2Neoplasms 1Colorectal Neoplasms 1Cancer: Breakthrough Pain 1Cancer Pain 1

Interventions

Cisplatin 62Carboplatin 52Paclitaxel 48Radiotherapy 47Docetaxel 41Gemcitabine 38Cyclophosphamide 36Rituximab 33Capecitabine 28Fluorouracil 27Dexamethasone 27Doxorubicin 26Prednisone 21Bevacizumab 20Pemetrexed 19Oxaliplatin 18Leucovorin 18pembrolizumab 17Vincristine 17Etoposide 17Cytarabine 15Drug Therapy 14Irinotecan 13Imatinib Mesylate 13Filgrastim 13Zoledronic Acid 12Radiosurgery 12Erlotinib Hydrochloride 12Trastuzumab 11Goserelin 11

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × Morphine × Clear all
NCT01318161 2021-02-16

EPICOL

Örebro University, Sweden

Phase 3 Terminated
221 enrolled
Gastrointestinal

Pain, Colorectal Neoplasms

NCT00505414 2019-11-01

A Study to Evaluate the Effectiveness and Safety of CG5503 (Tapentadol) in the Treatment of Chronic Tumor Related Pain Compared With Placebo and Morphine

Grünenthal GmbH

Phase 3 Terminated
136 enrolled 9 charts

Neoplasms, Pain

NCT02591017 2018-11-13

ONKEMI

University Hospital, Basel, Switzerland

Phase 3 Terminated
11 enrolled

Cancer: Breakthrough Pain

NCT00634010 2016-05-09

Morphine Versus Methadone As First Line Strong Opioid for Cancer Pain

M.D. Anderson Cancer Center

Phase 3 Terminated
36 enrolled 6 charts

Cancer Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡